| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.47B | -10.1% |
| Cost of Revenue | $1.35B | -8.0% |
| Gross Profit | $118.8M | -28.3% |
| R&D Expense | $7.0M | +40.0% |
| SG&A Expense | $83.9M | -9.0% |
| Operating Income | $4.1M | -89.6% |
| Pre-tax Income | -$95.0M | -93.2% |
| Income Tax | $323.3M | +3720.8% |
| Net Income | -$420.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.4M | -39.8% |
| Accounts Receivable | $193.3M | -9.7% |
| Inventory | $238.0M | +14.4% |
| Current Assets | $568.4M | -5.4% |
| Total Assets | $1.76B | -17.4% |
| Current Liabilities | $360.4M | -9.9% |
| Long-term Debt | $758.1M | +7.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $23.9M | -88.3% |
| Investing Cash Flow | -$114.1M | -5.7% |
| Financing Cash Flow | $30.1M | +170.8% |
| -985.8% |
| EPS (Basic) | -$6.33 | -972.9% |
| EPS (Diluted) | -$6.33 | -972.9% |
| Stockholders' Equity |
| $316.6M |
| -55.7% |